| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $84.6M | — | -11.5% |
| SG&A Expense | $24.6M | — | -12.1% |
| Operating Income | -$109.2M | — | +11.6% |
| Pre-tax Income | -$100.8M | — | +11.8% |
| Income Tax | $7K | — | — |
| Net Income | -$100.8M | — | +11.9% |
| EPS (Basic) | -$0.16 | — | +23.8% |
| EPS (Diluted) | -$0.16 | — | +23.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $145.1M | -37.1% | -5.5% |
| Short-term Investments | $759.6M | +2.6% | +7.5% |
| Current Assets | $915.9M | -6.7% | +5.1% |
| Total Assets | $1.23B | -6.0% | -2.4% |
| Current Liabilities | $43.8M | -28.9% | -16.3% |
| Total Liabilities | $119.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$59.5M | — | +2.0% |
| Capital Expenditures | $10.0M | — | +71.0% |
| Investing Cash Flow | -$25.7M | — | -141.4% |
| Financing Cash Flow | -$256K | — | -102.2% |
| Free Cash Flow | -$69.5M | — | -4.4% |
| -20.5% |
| Stockholders' Equity | $1.11B | -5.1% | +0.1% |